Cross-Sectional and Prospective Associations Between Proinsulin and Cardiovascular Disease Risk Factors in a Population Experiencing Rapid Cultural Transition

  1. Anthony J.G. Hanley, PHD12,
  2. Gail McKeown-Eyssen, PHD1,
  3. Stewart B. Harris, MD3,
  4. Robert A. Hegele, MD4,
  5. Thomas M.S. Wolever, MD5,
  6. Jeremy Kwan, MSC6,
  7. Philip W. Connelly, PHD7 and
  8. Bernard Zinman, MD28
  1. 1Department of Public Health Sciences, University of Toronto, Toronto
  2. 2Samuel Lunenfeld Research Institute, Mt. Sinai Hospital, Toronto
  3. 3Centre for Studies in Family Medicine, University of Western Ontario
  4. 4Robarts Research Institute, London
  5. 5Department of Nutritional Sciences and the
  6. 6Banting and Best Diabetes Centre, University of Toronto, Toronto
  7. 7Departments of Medicine, Biochemistry, and Laboratory Medicine and Pathobiology, St. Michael’s Hospital, University of Toronto, Toronto
  8. 8Division of Endocrinology and Metabolism, Mt. Sinai Hospital and University Health Network, Toronto, Ontario, Canada

    Abstract

    OBJECTIVE—To examine cross-sectional and prospective associations between proinsulin and cardiovascular disease risk factors using data from a population-based study of type 2 diabetes among Native Canadians.

    RESEARCH DESIGN AND METHODS—Between 1993 and 1995, 72% of eligible members of a Native Canadian community participated in a baseline diabetes prevalence survey. Fasting samples were collected for glucose, C-peptide, proinsulin, lipids, and apolipoproteins. A 75-g oral glucose tolerance test was administered, and a second sample for glucose was drawn after 120 min. Blood pressure and waist circumference were determined. In the present study, subjects with normal glucose tolerance (NGT) (n = 505) and impaired glucose tolerance (IGT) (n = 74) were included in cross-sectional analyses. In 1998, 95 individuals who had IGT or NGT at baseline with an elevated 2-h glucose concentration (≥7.0 mmol/l) participated in a follow-up evaluation using the protocol used at baseline. Cross-sectional and prospective associations between proinsulin and cardiovascular risk factors were assessed using correlation and multiple linear regression analyses.

    RESULTS—After adjustment for covariates including age, sex, C-peptide, waist circumference, and glucose tolerance status, fasting proinsulin concentration was significantly associated with concurrently measured lipid and apolipoprotein concentrations (triglycerides: r = 0.18, P < 0.0001; total cholesterol: r = 0.10, P = 0.02; LDL cholesterol: r = 0.11, P = 0.01; HDL cholesterol: r = −0.16, P = 0.0002; apolipoprotein (apo) B: r = 0.17, P < 0.0001; apoAI: r = −0.11, P = 0.008). In the adjusted prospective analysis, baseline triglycerides, HDL cholesterol, and apoB were associated with changes over time in proinsulin (r = 0.23, P = 0.04; r = −0.30, P = 0.01; r = 0.23, P = 0.04; respectively).

    CONCLUSIONS—These results confirm previously reported cross-sectional associations between proinsulin and lipid concentrations. In addition, an unexpected association between baseline lipids and proinsulin change was documented.

    Footnotes

    • Address correspondence and reprint requests to Bernard Zinman, MD, Division of Endocrinology and Metabolism, Mt. Sinai Hospital, 600 University Ave., Suite 782, Toronto, Ontario, M5G 1X5, Canada. E-mail: zinman{at}mshri.on.ca.

      Received for publication 22 December 2000 and accepted in revised form 20 March 2001.

      A table elsewhere in this issue shows conventional and Système International (SI) units and conversion factors for many substances.

    « Previous | Next Article »Table of Contents